Progress Beyond the DNA Profile to Human Identification
For cases requiring human identification, a technology that can produce potent analytical intelligence from a DNA sample is required.
Verogen can provide a range of abilities, accessible only through the MiSeq FGx Forensic Genomics Solution, including:
- Forensic genetic genealogy, allowing users to broaden their web of data to identify an individual
- Mitochondrial DNA sequencing, enabling the extraction of further data from complex samples
- SNP sequencing, which provides physical trait estimates and more
This summary demonstrates how these exclusive abilities progress DNA analysis from the production of a profile to the delivery of human identification.
About Verogen, Inc.
Introducing the world’s first sequencing company solely dedicated to forensic science. Forensic laboratories are unique, and require unique scientific solutions.
We get this. Because we live it. We create thoughtfully tailored genomic solutions for forensic DNA labs. The kinds of tools we longed for when we worked in those labs ourselves. We formed an independent company with dedicated resources because we believe it’s the best way to fully address those unique needs.
The last few decades have seen tremendous advancements in molecular biology techniques, such as massively parallel sequencing. While our colleagues in other scientific fields have embraced and benefited from these improvements, forensic genomics has yet to realize the potential of the evolved technology. It’s time we had modern tools tailored to our needs.
Verogen understands this. Our sole focus is to advance science to help unlock the true potential of forensic genomics. Powered by Illumina technology and free of legacy method allegiance, we are uniquely positioned to support forensic labs with innovative solutions purpose-built for the challenges of DNA identification. Working in partnership with the community, we can elevate the forensic genomics lab’s role in preserving public safety—and improve global justice for all.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.